{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:43:20Z","timestamp":1792734200390,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/ico.0b013e31829ebb0d","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T09:18:56Z","timestamp":1378372736000},"page":"1591-1598","source":"Crossref","is-referenced-by-count":10,"title":["Presurgical Corticosteroid Treatment Improves Corneal Transplant Survival in Mice"],"prefix":"10.1097","volume":"32","author":[{"given":"Hyun Kyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin A.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurali K.","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713689508999908","article-title":"Steroid inhibition of limbal blood and lymphatic vascular cell growth.","volume":"14","author":"Boneham","year":"1995","journal-title":"Curr Eye Res"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10792-007-9100-7","article-title":"Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.","volume":"28","author":"Tabbara","year":"2008","journal-title":"Int Ophthalmol"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":". Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells.","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/ICO.0b013e3182473356","article-title":". Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model.","volume":"31","author":"Cho","year":"2012","journal-title":"Cornea"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00007890-199210000-00026","article-title":"Orthotopic corneal transplantation in miceevidence that the immunogenetic rules of rejection do not apply.","volume":"54","author":"Sonoda","year":"1992","journal-title":"Transplantation"},{"key":"R9-15-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IIO.0b013e3181924e23","article-title":"Corneal graft rejection.","volume":"49","author":"Lam","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group.","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R11-15-20210204","first-page":"2176","article-title":"Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.","volume":"36","author":"Sano","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-15-20210204","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ACI.0b013e32833dfa11","article-title":"High-risk corneal allografts and why they lose their immune privilege.","volume":"10","author":"Niederkorn","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":". Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.","volume":"129","author":"Hos","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R14-15-20210204","first-page":"330","article-title":"Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).","volume":"105","author":"Dana","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R15-15-20210204","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","article-title":"Evaluation of topical ciclosporin 0.05 for prevention of rejection in high-risk corneal grafts.","volume":"92","author":"Unal","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R16-15-20210204","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization.","volume":"37","author":"Dana","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-15-20210204","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":". Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-15-20210204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ophtha.2011.10.016","article-title":". Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.","volume":"119","author":"Shimazaki","year":"2012","journal-title":"Ophthalmology"},{"key":"R21-15-20210204","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s004170000242","article-title":". The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.","volume":"239","author":"Claerhout","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-15-20210204","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":". VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"key":"R23-15-20210204","first-page":"632","article-title":". Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation.","volume":"11","author":"Yamagami","year":"2005","journal-title":"Mol Vis"},{"key":"R24-15-20210204","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/09273948.2010.486100","article-title":"Immune privilege of corneal allografts.","volume":"18","author":"Niederkorn","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"R25-15-20210204","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":". Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R26-15-20210204","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":". Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival.","volume":"51","author":"Dastjerdi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-15-20210204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":". Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.","volume":"126","author":"Bachmann","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R28-15-20210204","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1167\/iovs.11-7454","article-title":". Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-15-20210204","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjo.2010.201939","article-title":". The effect of perioperative allergic conjunctivitis on corneal lymphangiogenesis after corneal transplantation.","volume":"95","author":"Flynn","year":"2011","journal-title":"Br J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31829ebb0d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:36:01Z","timestamp":1621884961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201312000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31829ebb0d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}